search
Back to results

Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea

Primary Purpose

Acute Diarrhea

Status
Completed
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
Actitan F
Standard Oral Rehydration
Sponsored by
Federico II University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Diarrhea

Eligibility Criteria

3 Months - 12 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients enrolled were children from 3 months to 12 years old, with a diagnosis of acute diarrhea appeared less than 7 days before the admission, capability to oral rehydration, mild to moderate dehydration.

Exclusion Criteria:

  • Patients with diarrhea over 7 days, serious somatic pathology and severe dehydration were excluded.

Sites / Locations

  • Marina Russo

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group 1

Group 2

Arm Description

Group 1 consisting of 30 children treated with Actitan F and standard oral rehydration (SOR)

Group 2 consisting of 30 children who received only SOR.

Outcomes

Primary Outcome Measures

effectiveness of a medical device made of Actitan-F in the treatment of acute diarrhea, valuated on the basis of consistency of stools based on Bristol Stool Form
the effectiveness of a medical device made of Actitan-F, a natural molecular complex of tannins (from Agrimony and Tormentil) and flavonoids (Chamomile), in the treatment of acute gastroenteritis (AG) in children, valuated on the basis of stool consistency
effectiveness of a medical device made of Actitan-F in the treatment of acute diarrhea, valuated on the basis of number of stools / day
he effectiveness of a medical device made of Actitan-F, a natural molecular complex of tannins (from Agrimony and Tormentil) and flavonoids (Chamomile), in the treatment of acute gastroenteritis (AG) in children, valuated on the basis of number of stools/day

Secondary Outcome Measures

Full Information

First Posted
November 16, 2017
Last Updated
November 28, 2017
Sponsor
Federico II University
search

1. Study Identification

Unique Protocol Identification Number
NCT03356327
Brief Title
Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea
Official Title
Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea : A Pilot, Randomized, Control-case Study
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
April 1, 2017 (Actual)
Primary Completion Date
July 31, 2017 (Actual)
Study Completion Date
November 1, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federico II University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A pilot, randomized, case-controlled trial was conducted in 60 children affected by AG (< 7 days) with mild-moderate dehydration, according to WHO recommendations, from1 year to 17 years old. Patients were divided into 2 Groups: Group 1 consisting of 30 children treated with Actitan F and standard oral rehydration (SOR); Group 2 consisting of 30 children who received only SOR. Both groups received treatment for seven days, respectively. Patients of Group 1 stopped for their own choice, SOR after the first 24 h and continued only with Actitan F.
Detailed Description
The investigators included 60 children (mean age: 3.1yrs, range 0.3-12years) with a diagnosis of AG, referred between April and July 2017 to the Department of Translational Medicine, section of Pediatric, University of Naples Federico II. Patients enrolled were children from 3 months to 12 years old, with a diagnosis of acute diarrhea appeared less than 7 days before the admission, capability to oral rehydration, mild to moderate dehydration. Patients with diarrhea over 7 days, serious somatic pathology and severe dehydration were excluded. The study was approved by the Institutional Review Board of the University of Naples "Federico II" with the protocol number 25/17. At admission, written informed consent was obtained from participants' parents and from all patients older than 10 years. At first visit, a medical history was collected by one of the authors and all patients underwent clinical evaluation, including body weight and body temperature. Frequency of bowel movements, stool consistency measured through the Bristol Stool Form Scale (BSFS) and other associated gastrointestinal symptoms, including nausea, vomiting, abdominal pain and rectal bleeding, were accurately recorded. The BSFS is the most commonly standardized instrument used to rate stool consistency in children. On admission, the degree of dehydration was clinically determined for each patient, based on WHO recommendations and data were recorded on a scale from 1 to 3 (1 for mild or <5%; 2 for moderate or 5% to 10%; 3 for severe or 10% and more). Participants were randomly divided into two groups: Group 1 was treated with Actitan F and standard oral rehydration (SOR) and Group 2 was treated with SOR only ad libitum for 7 days. SOR is a reduced osmolarity oral solution (50/60 mmol/L Na), which is the first line therapy recommended by ESPGHAN guideline for Acute Diarrhea. Actitan F, instead, was orally administrated at dose of 1 sack every 4 hours, maximum 4 sacks/day for 7 days. Caregivers were instructed to administer the daily dose after mixing the contents of the sachet with a small amount of water. The study products used in this trial were donated by Aboca® Società Agricola SpA., Località Aboca, 20, 52037 Sansepolcro (AR) - Italy. At home, all parents had to fulfill a daily diary to record number and consistency of stools, presence of fever, vomiting and children compliance with the therapy. During the final visit, scheduled after 7 days, the interim history was assessed, daily diaries were reviewed and discussed, and a physical evaluation was performed. Outcomes The primary outcome was the duration of diarrhea, defined as the number of stools after 24 hours of treatment or the time needed to normalize number and consistency of stools (compared with the period before the onset of diarrhea). Secondary outcomes were the evaluation of vomiting, body weight, possible need of hospitalization, compliance to therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Diarrhea

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group 1
Arm Type
Experimental
Arm Description
Group 1 consisting of 30 children treated with Actitan F and standard oral rehydration (SOR)
Arm Title
Group 2
Arm Type
Active Comparator
Arm Description
Group 2 consisting of 30 children who received only SOR.
Intervention Type
Drug
Intervention Name(s)
Actitan F
Intervention Description
A molecolar complex of Tannins and Flavonoids used for acute diarrhea in children
Intervention Type
Drug
Intervention Name(s)
Standard Oral Rehydration
Intervention Description
Standard oral rehydration as suggested by ESPGHAN guidelines
Primary Outcome Measure Information:
Title
effectiveness of a medical device made of Actitan-F in the treatment of acute diarrhea, valuated on the basis of consistency of stools based on Bristol Stool Form
Description
the effectiveness of a medical device made of Actitan-F, a natural molecular complex of tannins (from Agrimony and Tormentil) and flavonoids (Chamomile), in the treatment of acute gastroenteritis (AG) in children, valuated on the basis of stool consistency
Time Frame
2 weeks
Title
effectiveness of a medical device made of Actitan-F in the treatment of acute diarrhea, valuated on the basis of number of stools / day
Description
he effectiveness of a medical device made of Actitan-F, a natural molecular complex of tannins (from Agrimony and Tormentil) and flavonoids (Chamomile), in the treatment of acute gastroenteritis (AG) in children, valuated on the basis of number of stools/day
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients enrolled were children from 3 months to 12 years old, with a diagnosis of acute diarrhea appeared less than 7 days before the admission, capability to oral rehydration, mild to moderate dehydration. Exclusion Criteria: Patients with diarrhea over 7 days, serious somatic pathology and severe dehydration were excluded.
Facility Information:
Facility Name
Marina Russo
City
Napoli
ZIP/Postal Code
80131
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29866147
Citation
Russo M, Coppola V, Giannetti E, Buonavolonta R, Piscitelli A, Staiano A. Oral administration of tannins and flavonoids in children with acute diarrhea: a pilot, randomized, control-case study. Ital J Pediatr. 2018 Jun 4;44(1):64. doi: 10.1186/s13052-018-0497-6.
Results Reference
derived

Learn more about this trial

Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea

We'll reach out to this number within 24 hrs